CONTRACT FOR CARE · RIGHTS, CONSENT & GOVERNMENT POWER
Our Legal Case
A patient’s need for medicine should not become the pressure used to obtain a criminal admission. Examine compulsory disclosures, penalties for silence, coerced rights waivers, and the circumstances behind the signature.
Use the original agreement and policy sources for this record to identify the exact clause, its legal source, and the stated consequence. Preserve those facts before reaching a conclusion about a particular provider or condition.
Apply the constitutional and consent review to this record
- Government responsibility: Which law, binding rule, agency instruction, or public-provider policy requires the particular disclosure or consequence? Separate it from provider-added terms.
- Potential criminal admission: Identify the exact spoken answer, written history, certification, or explanation and the real criminal risk it creates.
- Penalty for silence: Record what happens if the patient invokes the privilege or refuses a rights waiver, including denial, discharge, or interruption of treatment.
- Consent and pressure: Preserve the circumstances of signing, severity of pain, accessible alternatives, and whether the patient could honestly accept the prospective obligations.
- Criminal-use protection: Identify legally sufficient immunity and limits on use of both the answer and evidence derived from it. A privacy assurance is a separate protection.
Read the precedents, evidence framework, clause review, and remedies and reform demands. The work develops a proposed constitutional challenge; applying it to a particular condition requires its facts and legal authority.
MASSACHUSETTS · CONTRACT FOR CARE
Comprehensive Pain Management — Opioid Informed Consent
Public institutional form — current signed use unconfirmed
Document/version: Printed Revised 01/05/2017; linked October 12, 2026. 2 PDF pages.
Documented lockbox requirement is a practice implementation. General safe-storage subjects under a narrow professional rule do not establish this exact purchase/proof deadline. Current signed use remains unconfirmed.
Selected exact excerpt (p.2, starred initial line): bring a receipt
.
Requirements and documented consequences
This table paraphrases source-located terms. Use the original PDF for exact complete wording. PDF page numbers count from the first page, including packet covers.
| Source location | Requirement summary | Classification | Stated consequence |
|---|---|---|---|
| p.1, initial lines1–7 | Risks include sedation, dependence, addiction, interaction/overdose and impaired activity. | Required subject; method varies | No distinct penalty specified here. |
| pp.1–2 | Disclose personal/family risk history and opioid use to other providers. | Clinic term beyond §18A baseline | No distinct penalty specified here. |
| p.2, first sections | Discuss alternatives and incomplete pain relief. | Required subject; method varies | No distinct penalty specified here. |
| p.2, goals section | Stop opioids if treatment does not meet functional goals. | Clinic term beyond §18A baseline | Medication stopped if goals unmet. |
| p.2 | Discuss sex-specific risks and pregnancy notification. | Clinic term beyond §18A baseline | No distinct penalty specified here. |
| p.2, starred initial line | Obtain lockbox by next visit; show receipt or box. | Clinic term beyond §18A baseline | Purchase/proof obligation; no distinct penalty specified. |
| p.2, signature/contact fields | Patient and provider sign after questions; confirm contact for random visits. | Required subject; method varies | No distinct penalty specified here. |
Comparison with Massachusetts authority
M.G.L. c.94C §18A(b) requires an agreement addressing benefits and abuse/misuse risks when a registered practitioner recommends ER/LA opioids during long-term pain management. Record placement follows that subsection. Narrow hydrocodone professional rules, written informed-consent duties, and MassHealth coverage criteria are separate layers.
§18A does not itself prescribe these exact deadlines, charges, disclosure terms or dismissal mechanics. 243CMR2.07(25) addresses screening, counts and safe storage for a narrow formulation and patient-specific risk; §2.07(26) separately governs informed consent. A required subject does not make every implementation mandatory.
DIA’s October 2024 chronic-pain guideline addresses agreements, bilateral responsibilities and continuity within the injured-worker context. DIA says its guidelines are not mandates. Coverage terms must be mapped to the actual payer/program.
Connected offices
- Comprehensive Pain Management — Franklin — association, not confirmed signed use.
- Comprehensive Pain Management — Attleboro — association, not confirmed signed use.
Current copy and practice response
Patients can submit the version presented to them. Practices can supply a current blank form, dates, applicable offices/groups, exceptions and corrections. Historical versions remain linked. No motive or legality finding is made. Privacy, termination, pregnancy-testing and partial-fill interpretations remain open for owner/legal review.
Research: October 12, 2026. Methodology. Factual comparison published with stated interpretation limits.